Autoimmune Disease — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for autoimmune disease. 18 active patents protecting 2 drugs from 1+ originators. First major cliff: 2032. Daily refresh.

2
Approved drugs
18
Active US patents
70/100
Avg vulnerability
—
Annual revenue covered

Originators in Autoimmune Disease

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Schering) 18 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating autoimmune disease. Each bar = one year. Y-axis scaled to peak year (4 patents).

3
27
1
28
4
32
4
33
4
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Cortef
hydrocortisone
 Generic (originally Merck/Upjohn) 14 64 — 2032-11-19
Deltasone
prednisone
 Generic (originally Schering) 4 76 — 2027-08-03

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8168218 Deltasone method of use 80 2028-01-07
9504699 Deltasone method of use 75 2027-08-03
9504699 Deltasone method of use 75 2027-08-03
9504699 Deltasone method of use 75 2027-08-03
11904046 Cortef method of use 75 2043-02-23
12133914 Cortef method of use 75 2043-02-23
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9649280 Cortef method of use 62 2034-05-12
9649280 Cortef method of use 62 2034-05-12
9649280 Cortef method of use 62 2034-05-12
9649280 Cortef method of use 62 2034-05-12
9675559 Cortef method of use 62 2033-01-10
9675559 Cortef method of use 62 2033-01-10
9675559 Cortef method of use 62 2033-01-10
9675559 Cortef method of use 62 2033-01-10
9717740 Cortef method of use 62 2032-11-19
9717740 Cortef method of use 62 2032-11-19

Related